UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37 degrees C and for capsule biosynthesis
about
The Cryptococcus neoformans capsule: a sword and a shield.Characterization of glycoinositolphosphoryl ceramide structure mutant strains of Cryptococcus neoformans.Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule.Pbx proteins in Cryptococcus neoformans cell wall remodeling and capsule assembly.Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.Strategies for acquiring the phospholipid metabolite inositol in pathogenic bacteria, fungi and protozoa: making it and taking it.Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis.Brain inositol is a novel stimulator for promoting Cryptococcus penetration of the blood-brain barrierTranscription factor Nrg1 mediates capsule formation, stress response, and pathogenesis in Cryptococcus neoformans.Introns regulate gene expression in Cryptococcus neoformans in a Pab2p dependent pathway.Cryptococcus neoformans is internalized by receptor-mediated or 'triggered' phagocytosis, dependent on actin recruitment.Model-driven mapping of transcriptional networks reveals the circuitry and dynamics of virulence regulation.Parallel beta-helix proteins required for accurate capsule polysaccharide synthesis and virulence in the yeast Cryptococcus neoformans.Live Imaging of Host-Parasite Interactions in a Zebrafish Infection Model Reveals Cryptococcal Determinants of Virulence and Central Nervous System InvasionCapsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformansThe capsule of the fungal pathogen Cryptococcus neoformans.Inhibition of nucleotide biosynthesis potentiates the antifungal activity of amphotericin B.Fungal-induced cell cycle impairment, chromosome instability and apoptosis via differential activation of NF-κB.Proteomic profiling of the influence of iron availability on Cryptococcus gattii.The environmental yeast Cryptococcus liquefaciens produces capsular and secreted polysaccharides with similar pathogenic properties to those of C. neoformans.UGE1 and UGE2 regulate the UDP-glucose/UDP-galactose equilibrium in Cryptococcus neoformans.Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans.Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence.Cryptococcus neoformans senses CO2 through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1Neurovirulence of Cryptococcus neoformans determined by time course of capsule accumulation and total volume of capsule in the brain.Distribution of the O-acetyl groups and β-galactofuranose units in galactoxylomannans of the opportunistic fungus Cryptococcus neoformans.Comparative Ecology of Capsular Exophiala Species Causing Disseminated Infection in Humans.UDP-Glucuronic Acid Transport Is Required for Virulence of Cryptococcus neoformans.Xylose donor transport is critical for fungal virulence.Masking the Pathogen: Evolutionary Strategies of Fungi and Their Bacterial Counterparts.Cryptococcus neoformans can form titan-like cells in vitro in response to multiple signals.
P2860
Q24619875-5188E48C-B48D-4CCF-9A5E-AB18AFC164A7Q33279267-E04F0516-FCF8-46FE-9396-B3044AE7B713Q33533286-20732B4F-E9D6-464B-A9D3-B9DB7F5E69A3Q33766799-BA117FD5-AF07-4779-9023-312E7ABCC334Q33790656-80B2141F-AEE5-43D5-B3C8-F1427CBDDC15Q33894565-67C40961-460E-4CEB-ABC7-7C3438AFB4B1Q33928824-5C0064E6-3AD8-42EE-AE0A-032EDE500F16Q34594241-CF9F81E9-D193-4FD1-BBA8-CE84A0B42679Q34671842-9584EA6D-7974-4D48-928A-B74212147FACQ34718557-09CF6D3D-F6A6-40A8-A3D7-6E99EB887A2EQ34961874-5FC86F49-874C-4CF5-A961-D8BCDD9C53D5Q35106929-99F0BEB9-78C1-490A-9D5B-9BB53F64F7F1Q35561962-2D8B6BBA-78B5-439E-A2EF-C44617E7AB08Q35783648-2B76DD43-D1C7-41A3-86E4-06E4E6568050Q36177555-0024F29D-640B-4EEE-B0B1-D72AAE675548Q37051210-E579742D-7A08-4E14-A2AE-E7475FA7574DQ37066510-8603BA44-5DC2-4D01-A1EB-956CFC39828BQ37337879-AE41A456-F83C-4AFD-8387-63501A90F7B8Q37534681-630C0850-209F-4CDD-85C5-2E18263C7F8FQ39384062-568BB194-90BF-40C9-B8C3-0ECCA39AAAA1Q40228124-D3570658-90C5-4CB6-83D2-40CB3968FA96Q40238846-845B4311-D39A-41BD-8B1D-83C6A4E2A4C3Q41368021-49EF2CBE-883C-4EFE-9F39-9DC4B257A1CDQ41870667-49FAB0B1-ED59-44AF-AB4E-3453FAA1E928Q41913077-52EA4605-04C8-469F-B187-6E3794C30737Q41967903-D9C98F1C-9FB0-4E9D-9972-22386D90E351Q45912792-3F13AF97-E903-4FC7-9E3F-813A8FAACB5CQ46444722-BBB13A0C-69DB-4535-9FC7-DD7B714BD555Q47408961-006FF901-F9E5-4025-A46B-CA0F149DAF02Q47830888-CE306D12-6316-484A-90D1-12B1767E2D4BQ48218058-06305520-588D-4894-9AD8-0AF904A1BBD6Q49410181-574EC92E-69C4-46B9-B16B-185A16ADD9D8Q53818381-4A505296-CACC-4C27-B997-35A8DDF8328F
P2860
UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37 degrees C and for capsule biosynthesis
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
UGD1, encoding the Cryptococcu ...... C and for capsule biosynthesis
@ast
UGD1, encoding the Cryptococcu ...... C and for capsule biosynthesis
@en
UGD1, encoding the Cryptococcu ...... and for capsule biosynthesis.
@nl
type
label
UGD1, encoding the Cryptococcu ...... C and for capsule biosynthesis
@ast
UGD1, encoding the Cryptococcu ...... C and for capsule biosynthesis
@en
UGD1, encoding the Cryptococcu ...... and for capsule biosynthesis.
@nl
prefLabel
UGD1, encoding the Cryptococcu ...... C and for capsule biosynthesis
@ast
UGD1, encoding the Cryptococcu ...... C and for capsule biosynthesis
@en
UGD1, encoding the Cryptococcu ...... and for capsule biosynthesis.
@nl
P2860
P921
P1433
P1476
UGD1, encoding the Cryptococcu ...... C and for capsule biosynthesis
@en
P2093
Frédérique Moyrand
P2860
P304
P356
10.1128/EC.3.6.1601-1608.2004
P577
2004-12-01T00:00:00Z